An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking ...
Morning Overview on MSN
The FDA approved a cell therapy to curb a deadly complication of stem-cell transplants
Children who survive a stem-cell transplant only to watch their own donor cells attack their organs now have a ...
CellDrop Biosciences Inc., a University of Wyoming spinout company developing advanced cell-processing technologies, has ...
Ischemic heart disease (IHD), also known as coronary artery disease, is a leading cause of death and morbidity in Western ...
Ischemic heart disease (IHD), also known as coronary artery disease, is a leading cause of death and morbidity in western ...
Ms. Washburn has over 20 years of experience in leadership roles in the pharmaceutical and biotech sectorsCorporate focus on delivering top-line ...
MuseCell Innovations (MCI), the exclusive global licensor of Dezawa MuseCells®, today announced its U.S. launch. By making this restorative therapy available domestically, MCI eliminates the need for ...
Introduction Bronchopulmonary dysplasia (BPD) remains a major complication among extremely low gestational age (ELGA) infants ...
Orca Bio has become a commercial-stage company with the FDA approval of Tregzi, a cell-based immunotherapy designed to ...
Money.ca on MSN
Stem-cell tourism is costing Canadians tens of thousands — and more, especially when multiple risks can outweigh the results
From TikTok testimonials to $30,000 trips abroad, more Canadians are chasing experimental treatments that Health Canada ...
Getting it over the finish line was a labor of love—and now, more than five years after her death, the lab of former Sloan ...
A new experimental model has illustrated how NF-1 tumors progress. Researchers have used the model for high-throughput ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results